国际肿瘤学杂志 ›› 2013, Vol. 40 ›› Issue (1): 21-24.

• 综述 • 上一篇    下一篇

经修饰DC疫苗抗肿瘤作用的研究进展

邱辉, 张俊萍   

  1. 030001太原,山西医科大学研究生学院(邱辉);山西医学科学院山西大医院生物治疗科(张俊萍)
  • 出版日期:2013-01-08 发布日期:2013-01-15
  • 通讯作者: 张俊萍,E-mail:junpingzhang-118@163.com E-mail:junpingzhang-118@163.com

Research progress of anti-tumor effect of the modified DC vaccine

QIU  Hui, ZHANG  Jun-Ping   

  1. Graduate School, Shanxi Medical University, Taiyuan 030001, China
  • Online:2013-01-08 Published:2013-01-15
  • Contact: Corresponding author: ZHANG Jun-ping, E-mail: junpingzhang-118@163.com E-mail:junpingzhang-118@163.com

摘要: 树突状细胞(DC)是体内最强的专职抗原提呈细胞,近年来,DC疫苗成为肿瘤治疗研究的热点之一,人们用各种基因修饰DC疫苗,解决了肿瘤细胞免疫原性弱和DC抗原提成能力低所引起的抗原解离以及肿瘤免疫逃逸等问题,诱导产生更强的抗肿瘤免疫反应,达到抑瘤、减瘤的效果,为肿瘤患者带来新的希望。

关键词: 树突细胞, 转染, 肿瘤, 免疫疗法

Abstract: Dendritic cells is the most powerful professional antigen presenting cells in vivo. In recent years, DC vaccine has become one of the research hotspots in tumor treatment. DC vaccine which is modified by varieties of genes can solve antigens dissociation and tumor immune escape and so on caused by the weak tumor cell immunogenicity and lower DC antigen commission ability, and can induce stronger antitumor immune response, which can achieve inhibitory tumor, reduce tumor effect and brings new hope for patients with tumor.

Key words: Dendritic cells, Transfection, Neoplasms, Immunotherapy